Epidermal growth factor receptor inhibitors selectively inhibit the expressions of human β-defensins induced by

Kio Park1, Rie Ommori2, Kyoko Imoto2

  • 1Department of Dermatology, Yamato Takada Municipal Hospital, Nara, Japan; Department of Dermatology, Nara Medical University, Nara, Japan.

Abstract

Insights

Epidermal growth factor receptor inhibitors (EGFRIs) can alter skin immunity. These cancer drugs may cause side effects by affecting human beta-defensins (hBDs) in response to bacteria.

Area of Science:

  • Dermatology
  • Oncology
  • Immunology

Background:

  • Epidermal growth factor receptor inhibitors (EGFRIs) are used to treat various cancers.
  • Dermatological side effects, like acneiform eruptions, are common with EGFRIs, but their mechanisms are unclear.

Purpose of the Study:

  • To investigate how EGFRIs affect human beta-defensin (hBD) expression against staphylococci.
  • To elucidate the pathomechanism of EGFRIs-induced cutaneous adverse reactions.

Main Methods:

  • Human beta-defensins 1, 2, and 3 (hBD1, hBD2, hBD3) expression was studied in normal human epidermal keratinocytes (NHEKs).
  • NHEKs were stimulated with Staphylococcus aureus and S. epidermidis (live or supernatant) with or without gefitinib and erlotinib (EGFRIs).
  • hBD levels in culture supernatants were measured using enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • EGFRIs did not inhibit hBD1 and hBD3 expression induced by S. aureus.
  • EGFRIs suppressed hBD2 and hBD3 expression induced by S. epidermidis.

Conclusions:

  • EGFRIs may induce cutaneous adverse effects by selectively disrupting innate immune responses.
  • This disruption involves altered responses to both commensal and pathogenic bacteria.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
190
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
954